---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-24-046223"
form_type: "8-K"
ticker: "AQST"
cik: "0001398733"
company_name: "Aquestive Therapeutics, Inc."
filed_at: "2024-11-07T23:59:59+00:00"
generated_at: "2026-05-30T03:23:56.877371+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "high"
source: SEC EDGAR
---

# Aquestive board member Santo J. Costa resigns; Cochran and Morris assume committee roles

## Summary
- Santo J. Costa resigned from board effective Nov 4, 2024 for personal reasons; no disagreement with company.
- John S. Cochran appointed Chair of Compensation Committee effective Nov 4, 2024.
- Timothy E. Morris added to Compensation Committee; board size reduced from 8 to 7 directors.
- Company thanked Costa for his years of service and dedication.

## SEC filing metadata
- accession: 0001628280-24-046223
- form_type: 8-K
- ticker: AQST
- cik: 0001398733
- company_name: Aquestive Therapeutics, Inc.
- filed_at: 2024-11-07T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1398733/000162828024046223/0001628280-24-046223-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1398733/000162828024046223/aqst-20241101.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-24-046223
- JSON: https://secwatch.observer/filing/0001628280-24-046223.json
- Plain text: https://secwatch.observer/filing/0001628280-24-046223.txt

## Key facts
- Executive change
  Santo J. Costa resigned as Director at Aquestive Therapeutics, Inc..
  - Action: resigned
  - Role: Director
  source text: On November 1, 2024, Santo J. Costa, a member of the Board of Directors of Aquestive Therapeutics, Inc. (the “Company”) and the Chairman of the Compensation Committee thereof (the “Compensation Committee”), notified the Company of his intention to resign from the Company's Board of Directors for personal reasons, effective November 4, 2024.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1398733/000162828024046223/0001628280-24-046223-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.